Gilman Law LLP Encourages Investors of Human Genome Sciences, Inc. To Inquire About Alleged Securiti

Gilman Law LLP, A National Law Firm Representing Victims of Securities Fraud, Is Actively Investigating A Class Action Lawsuit On Behalf of Investors of Human Genome Sciences, Inc. Naples, FL (PRWEB) December 30, 2011 Gilman Law LLP, a leading national securities law firm, is actively investigating shareholder allegations that Human Genome Sciences, Inc. (“HGS”) and certain of its officers and directors violated the Securities Exchange Act of 1934. If you purchased or otherwise acquired shares of Human Genome Sciences, Inc. between July 20, 2009 and November 11, 2010 (“Class Period”), i
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations